Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mutsuo Harano

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Biological Psychiatry|September 5, 2006
GABRB2 association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypesWing-Sze Lo, Mutsuo Harano, Micha Gawlik, et al.
Neuroscience Letters|February 19, 2008
Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependenceKyohei Otani, Hiroshi Ujike, Ayumu Sakai, et al.
Neuroscience Letters|April 17, 2009
An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosisKazuhiko Nakamura, Yoshimoto Sekine, Noriyoshi Takei, et al.
Annals of the New York Academy of Sciences|November 11, 2008
Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese populationTaro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, et al.
Annals of the New York Academy of Sciences|November 11, 2008
Prostate apoptosis response 4 gene is not associated with methamphetamine-use disorder in the Japanese populationTaro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 3, 2006
Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence/psychosisHideaki Kobayashi, Harumi Hata, Hiroshi Ujike, et al.
Annals of the New York Academy of Sciences|November 11, 2008
Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese populationTaro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 22, 2007
The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorderYukitaka Morita, Hiroshi Ujike, Yuji Tanaka, et al.
Biological Psychiatry|June 9, 2007
The dysbindin gene (DTNBP1) is associated with methamphetamine psychosisMakiko Kishimoto, Hiroshi Ujike, Yasuko Motohashi, et al.
Plos One|May 24, 2007
Positive selection within the Schizophrenia-associated GABA(A) receptor beta(2) geneWing-Sze Lo, Zhiwen Xu, Zhiliang Yu, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Biological Psychiatry|September 5, 2006
GABRB2 association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypesWing-Sze Lo, Mutsuo Harano, Micha Gawlik, et al.
Neuroscience Letters|February 19, 2008
Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependenceKyohei Otani, Hiroshi Ujike, Ayumu Sakai, et al.
Neuroscience Letters|April 17, 2009
An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosisKazuhiko Nakamura, Yoshimoto Sekine, Noriyoshi Takei, et al.
Annals of the New York Academy of Sciences|November 11, 2008
Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese populationTaro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, et al.
Annals of the New York Academy of Sciences|November 11, 2008
Prostate apoptosis response 4 gene is not associated with methamphetamine-use disorder in the Japanese populationTaro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 3, 2006
Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence/psychosisHideaki Kobayashi, Harumi Hata, Hiroshi Ujike, et al.
Annals of the New York Academy of Sciences|November 11, 2008
Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese populationTaro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 22, 2007
The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorderYukitaka Morita, Hiroshi Ujike, Yuji Tanaka, et al.
Biological Psychiatry|June 9, 2007
The dysbindin gene (DTNBP1) is associated with methamphetamine psychosisMakiko Kishimoto, Hiroshi Ujike, Yasuko Motohashi, et al.
Plos One|May 24, 2007
Positive selection within the Schizophrenia-associated GABA(A) receptor beta(2) geneWing-Sze Lo, Zhiwen Xu, Zhiliang Yu, et al.
Pageof 4